The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Identification of HER2 ultra-low based on an artificial intelligence (AI)-powered HER2 subcellular quantification from HER2 immunohistochemistry images.
 
Wonkyung Jung
Employment - Lunit
Stock and Other Ownership Interests - Lunit
 
Taebum Lee
Employment - Lunit
 
Sangwon SHIN
Employment - Lunit
 
Biagio Brattoli
Employment - Lunit
 
Mohammad Mostafavi
Employment - Lunit
 
Gahee Park
Employment - Lunit
Stock and Other Ownership Interests - Lunit
Patents, Royalties, Other Intellectual Property - hold patents
 
Sukjun Kim
Employment - Lunit
 
Hyunwoo Lee
No Relationships to Disclose
 
Yoon Ah Cho
No Relationships to Disclose
 
Eun Yoon Cho
No Relationships to Disclose
 
So-Woon Kim
No Relationships to Disclose
 
Sergio Pereira
Employment - Lunit
Stock and Other Ownership Interests - Lunit
 
Chang Ho Ahn
Employment - Lunit
 
Siraj Mahamed Ali
Employment - EQRX; EQRX (I); lunit
Leadership - Droplet Biosciences; Elevation Oncology; Incysus; Pillar Biosciences
Stock and Other Ownership Interests - Exelixis; Merus NV; Pfizer; Pfizer
Consulting or Advisory Role - Nexo TX; SRone
Patents, Royalties, Other Intellectual Property - patents via FOundation Medicine; Patents via Seres Health on microbiome stuff in non neoplastic disease (I)
 
Douglas E Mirsky
No Relationships to Disclose
 
Chan-Young Ock
Employment - Lunit
Leadership - Lunit
Stock and Other Ownership Interests - Lunit; Y-Biologics
Consulting or Advisory Role - Genome & Company; Idience; Medpacto; PIN therapeutics; Selecxine; Y-Biologics